Detalhe da pesquisa
1.
Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners.
J Oncol Pharm Pract
; 28(8): 1832-1847, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34693814
2.
Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety.
J Oncol Pharm Pract
; 26(5): 1225-1229, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32408842
3.
Complete metabolic response following anaplastic lymphoma kinase (ALK) targeted therapy in a patient with adenocarcinoma of unknown primary with immunohistochemistry/fluorescence in situ hybridisation discordant ALK test results.
Intern Med J
; 51(8): 1355-1356, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423539
4.
Optimal first-line treatment for metastatic ALK+ non-small cell lung cancer-a narrative review.
Transl Lung Cancer Res
; 12(2): 369-378, 2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36895924
5.
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis.
Asia Pac J Clin Oncol
; 18(6): 642-649, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098653
6.
Pilot Study of Patients' Preferences for Immediate Resection Versus a Watch and Wait Approach After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer.
JCO Oncol Pract
; 17(2): e149-e157, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926663
7.
Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians.
ESMO Open
; 5(6): e001090, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262203